Phenylketonuria (PKU) and related aromatic amino acid disorders arise from enzymatic deficiencies that disrupt the metabolic conversion of phenylalanine to tyrosine, specifically involving the enzyme phenylalanine hydroxylase or its co-factor regeneration systems. When primary catalytic pathways fail due to autosomal recessive genetic defects, substrates divert into alternative routes producing toxic accumulation of phenylketones (e.g., phenylpyruvate) and deficient synthesis of tyrosine-derived compounds like melanin and catecholamines. This theoretical framework establishes the biochemical causality linking specific enzyme deficits to distinct clinical manifestations such as intellectual disability, hypopigmentation, and characteristic metabolic byproducts in excretions within human biochemistry pathology.
Phenylketonuria (PKU) and related aromatic amino acid disorders arise from enzymatic deficiencies that disrupt the metabolic conversion of phenylalanine to tyrosine, specifically involving the enzyme…